Perimenopause:
what changes before we understand why
Something has changed. Sleep, first, tearing apart in the middle of the night for no apparent reason. Thermal regulation going haywire at odd times. Word-recall hesitating. Mood taking unexpected turns. And no one, in the fifteen-minute appointment, names what is happening.
Perimenopause is not a failure. It is an ordered neuroendocrine transition lasting on average four to eight years, preparing the body for a new hormonal equilibrium. The ovaries are not giving up: they are reorganising. Estradiol ceases to be predictable, and every organ that depended on it—from brain to bone to heart—goes through an adjustment period. It is also the window where hormonal longevity for the next thirty years is set.
This page is not going to tell you what to do. It will tell you what is happening, in the language science uses when it does not over-simplify.
The framework
What is actually called perimenopause — the STRAW+10 classification.
What is actually called perimenopause
The term 'perimenopause' has long meant anything and everything. In 2011, an international consensus renamed STRAW+10 established a precise classification, now the reference in clinical research and endocrinology. The study published by Harlow and collaborators in 2012 divides reproductive life into seven stages, two of which cover perimenopause.
Four systems affected at once
Sleep, brain, bones, heart: four territories reconfigured in parallel, at different paces.
Sleep tearing apart
Around three in the morning, sleep breaks. Estradiol and progesterone at steady state exert a calming effect on the autonomic nervous system; when they oscillate, hypothalamic KNDy neurons become hypersensitive, trigger hot flashes, and activate the HPA axis. Cortisol rises where it should fall.
Direct implication: treating sleep without treating the stress axis in perimenopause means addressing only half the problem.
The therapeutic window
What science really says about the timing of hormone treatment.
WHI 2002: what was misread
For twenty years, HRT was associated with the word risk. The initial 2002 publication stopped its estrogen-progestogen arm due to increased cardiovascular and breast-cancer risk. The methodological detail was ignored: the mean age of women included was 63, on average 12 years after their menopause.
Functional assessment
What a functional assessment evaluates first — five dimensions to weigh.
Five dimensions to assess
Perimenopause simultaneously puts strain on sleep, the adrenal axis, glucose metabolism, bone structure, and inflammatory terrain. A functional assessment does not treat 'menopause': it evaluates these five dimensions and prioritises those showing the most fragility.
Dive into a specific system
Access all Nutrilexic articles for 7 days · €5. (validated by the most recent peer-reviewed scientific publications)
Why do you wake up at 3am?
The word on the tip of your tongue
Hormones, phytotherapy, nothing at all: how to choose?
Plants for menopause: a measured hormonal support
This exploration is educational. It does not replace individualised medical advice, particularly for the decision about hormone treatment, which requires specialist consultation. Terms and conditions →
- Harlow SD et al.. « Executive summary of the Stages of Reproductive Aging Workshop +10 ». J Clin Endocrinol Metab, 2012.
- Joffe H et al.. « Vasomotor symptoms, sleep disturbance, and cortisol regulation in midlife women ». J Clin Endocrinol Metab, 2023.
- Greendale GA et al.. « Effects of the menopause transition and hormone use on cognitive performance ». Neurology, 2009.
- Greendale GA et al.. « Bone mineral density loss in relation to the final menstrual period ». J Bone Miner Res, 2012.
- Walters MJ et al.. « Cognitive trajectories across the menopause transition: a systematic review and meta-analysis ». Menopause, 2026 (in press).
- Watson SL et al.. « High-Intensity Resistance and Impact Training (LIFTMOR) improves bone density in postmenopausal women ». J Bone Miner Res, 2018.
- El Khoudary SR et al.. « Menopause Transition and Cardiovascular Disease Risk (AHA Scientific Statement) ». Circulation, 2020.
- Manson JE et al.. « Menopausal hormone therapy and long-term all-cause and cause-specific mortality ». JAMA, 2017.
- Gu Y et al.. « Timing and cardiovascular outcomes of menopausal hormone therapy: a comprehensive review ». Menopause, 2024.
- Contreras Garza et al.. « Endothelial estrogen receptor responsiveness and the timing hypothesis: mechanistic update ». J Clin Endocrinol Metab, 2025.
- Bauer J et al.. « Evidence-based recommendations for optimal dietary protein intake in older people (PROT-AGE) ». J Am Med Dir Assoc, 2013.